Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  2015-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.leukres.2015.06.004PMID 26159495
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia

  2014cited by this paper
• miR-2909-mediated regulation of KLF4: a novel molecular mechanism for differentiating between B-cell and T-cell pediatric acute lymphoblastic leukemias

  2014cited by this paper
• Significance of SODD expression in childhood acute lymphoblastic leukemia and its influence on chemotherapy.

  2014cited by this paper
• MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia

  2014cited by this paper
• Antibody Therapy for Pediatric Leukemia

  2014cited by this paper
• Multi-Agent Chemotherapy Overcomes Glucocorticoid Resistance Conferred by a BIM Deletion Polymorphism in Pediatric Acute Lymphoblastic Leukemia

  2014cited by this paper
• FMNL1 promotes proliferation and migration of leukemia cells

  2013cited by this paper
• Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-κB target genes in human breast cancer

  2013cited by this paper
• Triptolide Inhibits MDM2 and Induces Apoptosis in Acute Lymphoblastic Leukemia Cells through a p53-Independent Pathway

  2012cited by this paper
• Targeting A20 enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells.

  2012cited by this paper
• Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome

  2011cited by this paper
• Treatment of Acute Lymphoblastic Leukemia in Adolescents and Young Adults

  2011cited by this paper
• A20 Modulates Lipid Metabolism and Energy Production to Promote Liver Regeneration

  2011cited by this paper
• Targeting A20 Decreases Glioma Stem Cell Survival and Tumor Growth

  2010cited by this paper
• Ca2+ influx via TRPC channels induces NF-kappaB-dependent A20 expression to prevent thrombin-induced apoptosis in endothelial cells.

  2010cited by this paper
• A20: from ubiquitin editing to tumour suppression

  2010cited by this paper
• TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma

  2009cited by this paper
• The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.

  2009cited by this paper
• A20 is overexpressed in glioma cells and may serve as a potential therapeutic target

  2009cited by this paper
• TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.

  2009cited by this paper
• Frequent inactivation of A20 in B-cell lymphomas

  2009cited by this paper
• Biology and treatment of acute lymphoblastic leukemia.

  2008cited by this paper
• NF-kappa B genes have a major role in Inflammatory Breast Cancer

  2008cited by this paper
• A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells

  2007cited by this paper
• A20 inhibits NF-κB activation by dual ubiquitin-editing functions

  2005cited by this paper
• A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions.

  2005cited by this paper
• A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1‐dependent mechanism

  2005cited by this paper
• A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma

  1999cited by this paper
• Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene

  1996cited by this paper
• Biology and treatment of acute lymphoblastic leukemia

  1994cited by this paper
• The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity.

  1992cited by this paper
• Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin.

  1990cited by this paper
• Efficient transplantation of human non-T-leukemia cells into nude mice and induction of complete regression of the transplanted distinct tumors by ricin A-chain conjugates of monoclonal antibodies SN5 and SN6.

  1988cited by this paper

• A20 Facilitates Oxaliplatin Sensitivity in Colorectal Cancer Through Monoubiquitylation of IKK‐β

  2025cites this paper
• A20 inhibits doxorubicin-induced macrophage maturation and apoptosis through mTOR signaling in classical Hodgkin lymphoma

  2025cites this paper
• Cross-Sectional Study: Associations of A20 and Cezanne with Leukocyte Accumulation in B-Cell Acute Lymphoblastic Leukemia

  2025cites this paper
• Dissecting the dual role of OTU family proteins in tumor progression and immune escape

  2025cites this paper
• Downregulation of A20 Expression Related to T Cells by Staphylococcal Enterotoxin A Treatment

  2025cites this paper
• Real-Time Monitoring of NIH/3T3 Cell Growth and Drug Reaction Using Impedance Biosensors and Comparison with Biological Assays

  2025cites this paper
• Integrated transcriptome and cell phenotype analysis suggest involvement of PARP1 cleavage, Hippo/Wnt, TGF-β and MAPK signaling pathways in ovarian cancer cells response to cannabis and PARP1 inhibitor treatment

  2024cites this paper
• The A20/TNFAIP3-CDC20-CASP1 Axis Promotes Inflammation-mediated Metastatic Disease in Triple-negative Breast Cancer

  2022cites this paper
• Distinct phases of adult microglia proliferation: a Myc-mediated early phase and a Tnfaip3-mediated late phase

  2022cites this paper
• Distinct phases of adult microglia proliferation: a Myc-mediated early phase and a Tnfaip3-mediated late phase

  2022cites this paper
• Deubiquitinases in hematological malignancies

  2021cites this paper
• Potential of the tumor-derived extracellular vesicles carrying the miR-125b-5p target TNFAIP3 in reducing the sensitivity of diffuse large B cell lymphoma to rituximab

  2021cites this paper
• Ubiquitin–proteasome system (UPS) as a target for anticancer treatment

  2020cites this paper
• TNFAIP3 Suppresses Lung Cancer Progression via Regulating Cell Proliferation and Apoptosis

  2020cites this paper
• Functional analysis of deubiquitylating enzymes in tumorigenesis and development.

  2019cites this paper
• Genome-scale CRISPR activation screen uncovers tumor-intrinsic modulators of CD3 bispecific antibody efficacy

  2019cites this paper
• A20 at the Crossroads of Cell Death, Inflammation, and Autoimmunity.

  2019cites this paper
• Emerging role of zinc finger protein A20 as a suppressor of hepatocellular carcinoma

  2019influential citation
• Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.

  2017cites this paper
• Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer

  2017cites this paper
• TNFAIP3 inhibits migration and invasion in nasopharyngeal carcinoma by suppressing epithelial mesenchymal transition.

  2017cites this paper
• A20 Ameliorates Intracerebral Hemorrhage–Induced Inflammatory Injury by Regulating TRAF6 Polyubiquitination

  2017influential citation
• A20 promotes metastasis of aggressive basal-like breast cancers through multi-monoubiquitylation of Snail1

  2017cites this paper